USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
ALLUVIUM BIOSCIENCES, INC.
Address:
2574 BEDFORD RD
ANN ARBOR, MI 48104-4008
Phone:
N/A
URL:
N/A
EIN:
264652919
DUNS:
830576703
Number of Employees:
2
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $385,491.00 3
STTR Phase I $322,693.00 1

Award List:

A chemoenzymatic technology for the efficient synthesis of novel cryptophycins

Award Year / Program / Phase:
2009 / STTR / Phase I
Award Amount:
$322,693.00
Agency:
HHS
Principal Investigator:
Research Institution:
UNIVERSITY OF MICHIGAN
RI Contact:
N/A
Abstract:
DESCRIPTION (provided by applicant): The cryptophycins are a structurally diverse class of polyketide/non-ribosomal peptide natural products that possess potent anticancer activity. However, despite this impressive activity, the development of the cryptoph ycins into a beneficial cancer… More

A novel biosynthetic strategy for the production of a key cryptophycin precursor

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$114,971.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The cryptophycins are a structurally diverse class of polyketide/non-ribosomal peptide natural products that possess potent anticancer activity. In fact, a cryptophycin synthetic analogue has demonstrated promise in tre ating platinum resistant ovarian cancer.… More

A genetic engineering strategy for the improved production of the anti-helminthic

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$170,521.00
Agency:
HHS
Principal Investigator:
Jeffrey D. Kittendorf – 734-276-4921
Abstract:
DESCRIPTION (provided by applicant): Helminth infections are responsible for severe health problems worldwide, in both human and animal populations. It is estimated that 2-3 billion people, mainly from rural and impoverished regions of the world suffer from disease due to parasitic nematodes;… More

Development of a novel biocatalytic fatty acid decarboxylation technology for production of liquid biofuels

Award Year / Program / Phase:
2013 / SBIR / Phase I
Award Amount:
$99,999.00
Agency:
USDA
Principal Investigator:
Jeffrey D. Kittendorf, Vice President – 734-276-4921
Abstract:
Throughout the past decade, there has been increasing urgency to develop novel technologies for alternative energy sources. This is being driven by the consequential relationships of increased global consumption, rapidly diminishing fossil fuel reserves, growing national energy security concerns,… More